Health Condition 1: null- Dengue Fever Patient-3 days fever-severe body&joints pain-conjuntival congestion-retro bulbar tenderness-Rashes-headache-nausea
Conditions
Interventions
Intervention1: Repurposed 5 Antiviral Agents & 4 Anti-Cytokines: Antivirals:
1)Chloroquine 5mg /kg oral: 2mg/kg IM/IV
2)Doxycycline 100mg bid oral / IV
3)Prochloperazine 5mg bid oral / 12.5mg IV/I
Sponsors
MADURAIYIL SIVAKASI NADARS URAVINMURAI TRUST
BHARAT RATNA KAMARAJAR JAUNDICE LIVER HOSPITAL AND RESEARCH CENTRE
Eligibility
Inclusion criteria
Inclusion criteria: Dengue Fever Patient >3 days fever-severe body&joints pain-conjuntival congestion-retro bulbar tenderness-Skin and Hard Rashes-headache-nausea; male,female all age. Dengue detection Elisa NS1 IgM & IgG & DENV-RTPCR Viral Load. Serum Level of NS1, TNF-Alpha, Interleukin B1, Interleukin-6.
Exclusion criteria
Exclusion criteria: Other Super Added infection, if present - Malaria, Chikunkunya, Swine Flu, Etc.,
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 100% Recovery Possible because early intervention of category 1,2,3 - 0 to 2 pilot study category 4,5,6 may have partial recovery and mostly there will be no death in our protocol treatmentTimepoint: 100% Recovery Possible because early intervention of category 1,2,3 - 0 to 2 pilot study category 4,5,6 may have partial recovery and mostly there will be no death in our protocol treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Follow up re-assessment of recurrence of the particular geno type infectionTimepoint: 6 months to 2 years | — |
Countries
India
Contacts
Public ContactDr M Chandramohan
KAMARAJAR JAUNDICE LIVER HOSPITAL AND RESEARCH CENTRE - M.S.N.URAVINMURAI HOSPITAL
Outcome results
None listed